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Abstract
Background: Post-myocardial infarction (MI) depression is a highly prevalent disorder, affec-
ting nearly 18% of all MI patients, and it is a major predictor of disability in the year post-MI. 
We sought to expand this analysis by: comparing case-level anxiety, depression, and comorbid 
anxiety and depression as predictors of long term mortality during a 5-year follow-up period 
after MI; and investigating the role of potential modifying and confounding factors.
Methods: A total of 285 patients were screened on average 6 days after their MI and a 5-year 
survival rate was ascertained. The Beck Depression Inventory (BDI) and the State-Trait 
Anxiety Inventory (STAI) were completed by patients hospitalized for MI. In addition we tested 
the BDI × STAI interaction effect.
Results: During the 5 years of follow-up, cardiac mortality was assessed in 274 of 285 eligible 
patients. Of the 274 patients whose survival data were available, 91 (33.2%) died. At entry, 
BDI score of 192 (67.4%) patients was ≥ 10 and 145 (50.9%) patients had STAI score ≥ 40. 
Anxiety was not associated with mortality, whereas depression significantly predicted death, but 
this association was attenuated to non-significance with full adjustment with disease severity 
and confounders.
Conclusions: Depression following MI does not predict longer-term survival with full adjustment. 
(Cardiol J 2014; 21, 4: 370–377)
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Introduction
Post-myocardial infarction (MI) depression is 
a highly prevalent disorder, affecting nearly 18% 
of all MI patients [1, 2], and it is a major predictor 
of disability in the year post-MI. Moreover, the 
question arises whether depression following 
MI is a risk factor for cardiovascular morbidity 
and mortality. Although the number of positive 
studies in this field has been growing steadily, the 
discrepancies have continued since the publication 
of a few negative results [3–9]. Scant studies have 
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reported longer-term mortality data in MI patients; 
whereas one has found an association between an 
in-hospital depression and mortality 5 years later 
[10], the other has observed no association at 
3-year follow-up [11]. Although symptoms of de-
pression and anxiety overlap, little is known about 
how anxiety affects mortality, with reports of both 
positive and negative effects [12–15].
These apparently conflicting results prompted 
us to find an answer to the following question: “Is 
there any association between depression and the 
cardiovascular mortality following MI”? We had 
previously found that depression or anxiety would 
not predict a subsequent increase in mortality 
during a 24-month follow-up period after MI [8]. 
We sought to expand this analysis by: compa-
ring case-level anxiety, depression, and comorbid 
anxiety and depression as predictors of long term 
mortality during a 5-year follow-up period after MI; 
and investigating the role of potential modifying 
and confounding factors.
Methods
Between 2005 and 2010 all consecutive pa-
tients admitted to the coronary care units at Razi 
Hospital (Mazandaran University of Medical, 
Ghaemshahr, Iran) and Fatemeh Zahra Hospital 
(Mazandaran University of Medical, Sari, Iran) 
who met established criteria for MI were eligible 
for inclusion in the study. Patients were included if 
they met World Health Organization criteria for MI 
during their hospital admission [16]. Patients were 
excluded from the study if MI was the result of co-
ronary artery bypass graft surgery or angiography, 
if they had another medical condition likely to lead 
to death within the next 5 years and if they were 
unstable medically to complete the assessment 
even with assistance from the researcher. There 
were no age or gender restrictions. The study was 
approved by the ethics committees of the hospitals 
and was conducted in accordance with Helsinki 
Declaration.
Patients meeting the inclusion criteria were 
asked to participate as soon as they were medically 
stable and had been informed of their diagnosis, on 
average 6 days after their MI (range 2–15 days). 
After explaining the study and obtaining written 
informed consent, a research psychologist (inve-
stigator) conducted all baseline interviews which 
gathered routine demographic data, including age, 
gender, education, current partner status, history 
of smoking and alcohol use, history of thrombolytic 
therapy and any past medical history, including hi-
story of cardiovascular disease, diabetes mellitus, 
hypertension and past psychiatric history. Patients 
also completed a series of questionnaires. The 21- 
-item self-report Beck Depression Inventory (BDI) 
whose validity and reliability has been previously 
approved in Iran [17, 18] was used to assess the 
then current depressive symptoms. Scores of 10 
or higher were considered to indicate the presence 
of mild to severe symptoms of depression [19]. 
Anxiety was assessed with the Persian version of 
the Spielberger’s State-Trait Anxiety Inventory 
(STAI). The Persian version of STAI had been used 
in previous studies and its validity and reliability 
had been approved [20, 21]. The STAI, which com-
prises two self-report scales, was used to assess 
state anxiety. Scores of 40 or higher indicated the 
presence of anxiety symptoms [22].
The main outcome of this study was a 5-year 
cardiac mortality. We tested the BDI × STAI inte-
raction effect in addition to the BDI and STAI main 
effects. Employing these cut-offs, four groups were 
identified for the analysis: case-level anxiety only, 
case-level depression only, case-level comorbid 
anxiety and depression, and a reference group 
scoring below case-level on both scales.
Statistical analysis
Data were analyzed using SPSS for Windows, 
version 20. All statistical tests were 2-tailed; 
p values < 0.05 were considered statistically signi-
ficant. Categorical variables were compared using 
the c2 statistic or Fisher’s exact test, if necessary. 
Continuous variables were compared using indepen-
dent sample t-tests. The key outcome was cardiac 
mortality after MI. Cox regression models were 
used to quantify associations between anxiety, de-
pression and mortality, for investigation of confoun-
ding/mediating factors all demographic, clinical, and 
psychological variables that differentiated patients 
who died from those who survived were entered 
into a regression model. The same analyses were 
constructed for the dichotomized BDI (BDI score 
< 10 or ≥ 10, respectively) and state anxiety scores 
(dichotomized as < 40 and ≥ 40).
Results are presented as hazard ratios (HR) 
with 95% confidence interval (CI). Individuals 
still alive at the end of the follow-up comprised 
a common reference category.
Results
Participant characteristics
The mean age of participants was 59.1 ± 12.03 
years (range 24–85 years) and 197 (69.1%) were 
male; 105 (36.8%) participants were hypertensive, 
61 (21.4%) were diabetics, and 77 (27.0%) were 
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current cigarette smokers; 39 (13.7%) participants 
had suffered a previous MI and 105 (36.8%) recei-
ved thrombolytic therapy.
Baseline characteristics as a function  
of BDI or STAI status
Tables 1 and 2 show the baseline demographic, 
clinical and psychological information for partici-
pants with relatively high scores of depression 
and anxiety compared to those with relatively low 
scores during their hospital admission after acute 
MI. At entry, BDI score of 192 (67.4%) patients 
was ≥ 10 and 145 (50.9%) cases had STAI score 
≥ 40, respectively.
There were several differences between the 
groups: those with high BDI scores were more 
likely to be female, to have hypertension, diabetes 
or history of a previous MI, less to be current smo-
kers, and to have lower educational level. Anxiety 
was significantly associated with hypertension and 
lower educational level. Aside from a substantial 
association with state anxiety, BDI status was lin-
ked only to sex and diabetes in univariate analysis; 
women and patients with diabetes were more likely 
to register BDI scores ≥ 10.
Mortality and depression and  
anxiety disorders
Of the 285 completed baseline assessments, 
274 were traced on 5 years of follow-up. Of the 
274 patients whose survival data were available, 
91 (33.2%) died. Non-participants (patients who 
did not participate in the follow-up) were hetero-
geneous but did, on average, have poorer health 
than the participants. Comparison of the 91 dead 
subjects with the 183 living cases at the time of 
final assessment has been summarized in Table 3. 
Females were more likely to die, and the patients 
who died during the 5-year follow-up period were 
significantly older than those who survived, had 
more history of previous MI, received more throm-
bolytic therapy in the Index MI and had significantly 
higher BDI scores.
The data in Table 3 indicate that those who 
had died had higher BDI scores (depression score) 
at entry, but STAI score (anxiety score) was not 
Table 1. Baseline demographic and psychological data for participants according BDI scores.
All patients BDI score P
 
High (≥ 10) Low (< 10)
Number of subjects 285 192 93
Age [years] 59.1 ± 12.0 59.8 ± 12.3 57.5 ± 11.4 0.643
Gender (male) 197 (69.1%) 120 (62.5%) 77 (82.8%) 0.001
Current cigarette smoking 77 (27.0%) 43 (22.4%) 34 (36.6%) 0.012
Alcohol consumption 19 (6.7%) 13 (6.8%) 6 (6.5%) 0.919
Marital status*: 0.474
Single 2 (0.7%) 2 (1.1%) 0 (%)
Married 276 (96.8%) 184 (98.4%) 92 (100.0%)
Divorced 1 (0.03%) 1 (0.5%) 0(%)
Education level*: 0.027
Illiterate 136 (47.7%) 104 (55.3%) 32 (35.6%)
Primary school 57 (20.0%) 32 (17.0%) 25 (27.8%)
Secondary school 20 (70.2%) 13 (6.9%) 7 (7.8%)
Diploma 46 (16.1%) 26 (13.8%) 20 (22.2%)
University degree 19 (6.7%) 13 (6.9%) 6 (6.7%)
Diabetes 61 (21.4%) 49 (25.5%) 12(12.9%) 0.015
Hypertension 105 (36.8%) 84 (43.8%) 21 (22.6%) 0.001
Previous MI* 39 (13.7%) 34 (19.7%) 5 (6.3%) 0.007
Characteristics of index MI and its treatment:
Q-wave MI 97 (34.0%) 72 (37.5%) 25 (26.9%) 0.076
Thrombolysis 106 (37.2%) 83 (43.2%) 23 (24.7%) 0.002
Past psychiatric history 13 (4.6%) 11 (5.7%) 2 (2.2%) 0.233
Mean State-Trait Anxiety Inventory 33.9 ± 21.2 37.8 ± 21.2 26.0 ± 18.9 < 0.0001
*Complete data were not available for this variable; BDI — Beck Depression Inventory; MI — myocardial infarction
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different in those who had died and those who 
survived. However, dichotomized BDI scores 
also failed to predict mortality at 5 years. Neither 
state anxiety nor depression scores at entry were 
different between patients who died from those 
who survived. Of the 91 patients who died during 
the 5-year follow-up, 67 (73.6%) had BDI scores 
≥ 10 and 46 (50.5%) had STAI scores ≥ 40, while 
of the 183 survivors, 117 (63.9%) had BDI sco-
res ≥ 10 and 90 (49.2%) had STAI scores ≥ 40 
(p > 0.05 for each).
After adjustment for age and gender, the asso-
ciations among BDI score and mortality weakened 
but remained significant (unadjusted HR 1.032, 
95% CI 1.008–1.057, p = 0.010; adjusted HR 1.027, 
95% CI 1.0–1.054). When the relative contribution 
of all the above mentioned variables singly related 
to outcome was analyzed by cox regression ana-
lysis, older age (HR 1.096, 95% CI 1.062–1.132, 
p < 0.0001), and history of diabetes (HR 2.675, 
95% CI 1.191–6.008, p = 0.017) or previous MI 
(HR 3.181, 95% CI 1.329–7.615, p = 0.009) re- 
mained significantly and independently associated 
with mortality; the associations among BDI score 
and mortality attenuated to a non-significant trend 
(HR 1.017, 95% CI 0.987–1.047, p = 0.269).
Analysis of comorbidity
The diagnoses of depression and anxiety were 
significantly correlated (r = 0.269, p < 0.0001).
There were 74 (27.0%) cases with only depres-
sion and 26 (9.5%) with only anxiety; 110 (40.1%) 
participants had a diagnosis of both depression 
and anxiety. Percentages of patients who died 
with both comorbidities, depression only, anxiety 
only or neither are shown in Figure 1. There was 
no significant difference between the four study 
groups in the mortality rate. Simple effect analyses 
indicated that neither the value of depression for 
predicting cardiac mortality varied by the severity 
of comorbid anxiety, nor the value of anxiety for 
predicting cardiac mortality varied by the severity 
of comorbid depression. When comorbid with case-
-level depression, case-level anxiety was associa-
ted with a non-significant reduction in mortality 
(data not shown).
Table 2. Baseline demographic and psychological data for participants according STAI scores.
STAI score P
High (≥ 40) Low (<40)
Number of subjects (285) 145 140
Age [years] 59.9 ± 13.1 58.3 ± 10.8 0.820
Gender (male) 93 (64.1%) 104 (74.3%) 0.064
Current cigarette smoking 34 (23.4%) 43 (30.7%) 0.167
Alcohol consumption 11 (7.6%) 8 (5.7%) 0.527
Marital status*:  
Never married 1 (0.7%)  1 (0.7%) 0.594
Married 141 (99.3%)  135 (98.5%)
Divorced/separated/widowed 0 (0.0%) 1 (0.7%)
Education level*:
Illiterate 82 (58.6%) 54 (39.1%) 0.006
Primary school 21 (15.0%) 36 (26.1%)
Secondary school 12 (8.6%) 8 (5.8%)
Diploma 19 (13.6%) 27 (19.6%)
University degree 6 (4.3%) 13 (9.4%)
Diabetes 35 (24.1%) 27 (19.3%) 0.321
Hypertension 67 (46.2%) 39 (27.9%) 0.001
Previous MI* 23 (18.4%) 16 (12.6%) 0.203
Characteristics of index MI and its treatment:
Q-wave MI 39 (26.9%) 57 (40.7%) 0.014
Thrombolysis  60 (41.4%) 45 (32.1%) 0.106
Past psychiatric history 5 (3.4%) 8 (5.7%) 0.359
Mean Beck Depression Inventory 17.8 ± 10.4 12.2 ± 10.1 < 0.0001
*Complete data were not available for this variable; MI — myocardial infarction; STAI — State-Trait Anxiety Inventory
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Table 3. Baseline demographic and psychological data of patients who survived and died during the 
follow-up.
Survivors Fatalities RR (95% CI) P 
Number of subjects (274) 183 91
Age [years] 55.9 ± 11.1 65.9 ± 11.01 1.083 (1.055–1.111) < 0.0001
Gender:
Male 135 (73.8%) 55 (60.4%)
Female 48 (26.2%) 36 (39.6%) 1.841 (1.079–3.140) 0.025
Smoking status:
Current smoker 51 (27.9%) 21 (23.1%) 0.776 (0.433–1.394) 0.397
Nonsmoker 132 (72.1%) 70 (76.9%)
Alcohol consumption:
No 169 (92.3%) 87 (95.6%) 1.802 (0.576–5.639) 0.312
Yes 14 (7.7%) 4 (4.4%)
Marital status*:
Never married 1 (1.1%) 0 (0.0%) – –
Married 88 (98.9%) 179 (100.0%)
Divorced/separated/widowed 0 (0.0%) 0 (0.0%)
Education level*:
Illiterate 61 (67.0%) 71 (40.3%) – –
Primary school 16 (17.6%) 37 (21.0%)
Secondary school 3 (3.3%) 17 (9.7%)
Diploma 10 (11.0%) 34 (19.3%)
University degree 1 (1.1%) 17 (9.7%)
Diabetes:
No 153 (83.6%) 64 (70.3%) 2.152 (1.185–3.906) 0.012
Yes 30 (16.4%) 27 (29.7%)
Hypertension:
No 122 (66.7%) 51 (56.0%) 1.569 (0.937–2.627) 0.087
Yes 61 (33.3%) 40 (44.0%)
Previous MI*:
No 150 (91.5%) 57 (72.2%) 4.135 (1.981–8.635) < 0.0001
Yes 14 (8.5%) 22 (27.8%)
Thrombolysis:
Not thrombolyzed 124 (67.8%) 48 (52.7%) 1.883 (1.125–3.152) 0.016
Thrombolyzed 59 (32.2%) 43 (47.3%)
Past psychiatric history
No 173 (94.5%) 88 (96.7%) 0.590 (0.158–2.198) 0.431
Yes 10 (5.5%) 3 (3.3%)
BDI score (as continuous variable) 13.7 ± 9.8 17.3 ± 11.7 1.032 (1.008–1.057) 0.010
High BDI score (≥ 10):
No 66 (36.1%) 24 (26.4%) 1.575 (0.904–2.744) 0.109
Yes 117 (63.9%) 67 (73.6%)
STAI score (as continuous variable) 34.3 ± 19.8 32.6 ± 23.4 0.996 (0.984–1.008) 0.535
High STAI score (≥ 40):
No 93 (50.8%) 45 (49.5%) 1.056 (0.639–1.747) 0.831
Yes 90 (49.2%) 46 (50.5%)
*Complete date were not available for this variable; All demographic, clinical, and psychological variables that differentiated patients who died 
from those who survived were entered into a cox regression model; BDI — Beck Depression Inventory; CI — confidence interval; MI — myocar-
dial infarction; RR — relative risk; STAI — State-Trait Anxiety Inventory
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Discussion
In the present analysis, anxiety was not as-
sociated with mortality, whereas depression sig-
nificantly predicted death, but this association 
was abolished with full adjustment. Our finding of 
stronger mortality association in female partici-
pants between depression and mortality contrasts 
with the previously reported stronger effect in men 
than in women [23, 24].
A number of previous studies have evalu-
ated both anxiety and depression disorders and 
mortality in MI patients. High depression and 
anxiety values have both been shown to predict 
subsequent mortality [3, 7]. However, in some 
cases, symptoms of depression but not anxiety in 
multivariate models predicted mortality [5, 6], and 
in some, neither depression nor anxiety symptoms 
were found to predict mortality in MI patients 
[9]. Because the studies have varied in location, 
patient population, sample size, and the means of 
measuring depression, some variation in results is 
hardly surprising. In a previous analysis, we found 
that depression was not a stronger risk factor for 
post-MI mortality than for other causes combined 
during a 24-month follow-up [8]. A meta-analysis 
in 2004 [2] reported that post-MI depression is 
associated with a 2- to 2.5-fold increased risk of 
impaired cardiovascular outcome, and a recent 
meta-analysis in 2013 indicated that, although the 
association between depression following MI and 
prognosis is attenuated after adjustment for cardiac 
disease severity, depression remains independen-
tly associated with prognosis with a 22% increased 
risk of all-cause mortality and a 13% increased risk 
of cardiovascular events per standard deviation in 
depression z-score [25]. The relation of depression 
with cardiac mortality or all-cause mortality was 
more significant in the older studies (OR 3.22 
before 1992) than in the more recent studies (OR 
2.01 after 1992). This is despite the fact that in the 
recent large-scale intervention trial in MI patients 
with major or minor depression, the successful 
treatment of depression was successful in reducing 
symptoms, however it did not reduce mortality or 
the recurrence of MI over the average follow-up 
period of 41 months [26].
It seems more likely that controversies in 
results of depression and mortality in MI patients 
hinge on the issue of the relation between depres-
sion and disease severity. Depression and anxiety 
were associated with disease severity in some 
previous studies showing a relationship between 
these conditions and post-MI mortality and that 
disease severity is the underlying cause of death. 
It is worth noting that in a number of studies in 
which symptoms of depression were related to 
both short-term mortality following MI and disease 
severity, statistical control for disease severity 
attenuated the significant association between 
depression and mortality [27–30]. In some previous 
studies, depression was associated with the seve-
rity of cardiac disease. Therefore, the possibility 
of confounding factors that reduce the strength of 
the association between post-MI depression and 
cardiovascular prognosis cannot be fully ruled out. 
That is why depression and disease severity might 
be correlated in some studies but not in others; 
Carroll and Lane [31] have argued that it depends 
on the accuracy of patients’ perceptions of just how 
serious the event was and the likely prognosis.
The failure of some previous studies with ne-
gative results regarding the relationship between 
depression or anxiety with post-MI mortality, is 
attributed to the prevalence of mild symptoms 
among their patients [4, 32]. However, 67.4% of 
our patients scored ≥ 10 on the BDI and 50.9% 
scored ≥ 40 on the STAI, indicating mild to severe 
symptoms of depression and anxiety, respectively.
Depression and anxiety are highly comorbid 
psychiatric conditions [33]. In the present study, 
40.3% of total participants had a diagnosis of both 
depression and anxiety. More strikingly, 59.9% 
of those with a diagnosis of depression also had 
anxiety. The literature on anxiety and mortality is 
relatively sparse compared to that on depression. 
Figure 1. Mortality in each study comorbidity group.
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Previous studies have reported conflicting findings 
concerning the association between anxiety levels 
and mortality, which was reported as positive [12], 
absent [13, 14], and negative [15]. Furthermore, we 
found lower mortality in participants with comorbid 
anxiety and depression compared to those with 
depression alone. The latter finding is contrary to 
what seems intuitive, since comorbid anxiety and 
depression are associated with both poorer physical 
health [34] and more disability [35] than depression 
alone. We guess that low anxiety may result in 
reduced asking for help and reduced adherence to 
medications when somatic illness occurs [36], and 
may promote earlier identification and treatment of 
potentially life threatening disease and/or decrease 
risk behavior associated with non-disease mortality 
[15]. In other words, there may be an evolutionary 
benefit of moderate levels of anxiety, a hypothesis 
that needs further demonstration. These findings of 
differences between anxiety and depression might 
be an argument for maintaining the separation of 
the two disorders. Confounding is also unlikely 
since there was no apparent alteration following 
adjustment for the large number of covariates 
available for this analysis.
Limitations of the study
It should be conceded that there are a number 
of limitations to this analysis and its interpretation. 
First, our patients were hospitalized only for a few 
days and we did not regard the fluctuating distress 
reported by patients immediately after an MI as 
true depressive disorder. Furthermore, patients 
who were depressed at baseline were less likely 
to accept follow-up interviews than other patients. 
However, depression and anxiety at baseline were 
not related to lack of follow-up, so it is unlikely 
that the lack of interview data biased the results. 
To establish a causal relationship, we need longi-
tudinal research combining repeated measurement 
of depression and its presumed pathophysiological 
mechanisms, followed by adequately powered, 
randomized trials targeting the implicated me-
chanisms.
Conclusions
In conclusion, the present analysis showed 
that anxiety symptoms were not associated with 
mortality, whereas depressive symptoms signifi-
cantly predicted death, but this association was 
attenuated to no significance with full adjustment. 
In spite of non-significant results, with regard to 
the impact of depression and anxiety on cardiac 
outcome, it should be stressed that this does not 
mean that physicians and cardiologists can ignore 
depression.
Acknowledgements
This study was supported by a grant from 
Research Deputy at Mazandaran University of 
Medical Sciences.
The authors would like to thank Farzan In-
stitute for Research and Technology for technical 
assistance.
Conflict of interest: none declared
References
 1. Schleifer SJ, Macari-Hinson MM, Coyle DA et al. The nature and 
course of depression following myocardial infarction. Arch Intern 
Med, 1989; 149: 1785–1789.
 2. van Melle JP, de Jonge P, Spijkerman TA et al. Prognostic associa-
tion of depression following myocardial infarction with mortality 
and cardiovascular events: A meta-analysis. Psychosom Med, 
2004; 66: 814–822.
 3. Denollet J, Brutsaert DL. Personality, disease severity, and the 
risk of long-term cardiac events in patients with a decreased 
ejection fraction after myocardial infarction. Circulation, 1998; 
97: 167–173.
 4. Frasure-Smith N, Lespé rance Depression and anxiety as pre-
dictors of 2-year cardiac events in patients with stable coronary 
artery disease. Arch Gen Psychiatry, 2008; 65: 62–71.
 5. Frasure-Smith N, Lesperance F. Depression and other psycholo-
gical risks following myocardial infarction. Arch Gen Psychiatry, 
2003; 60: 627–636.
 6. Frasure-Smith N, Lesperance F, Talajic M. The impact of nega-
tive emotions on prognosis following myocardial infarction: Is it 
more than depression? Health Psychol, 1995; 14: 388–398.
 7. Herrmann C, Brand-Driehorst S, Kaminsky B, Leibing E, Staats 
H, Ruger U. Diagnostic groups and depressed mood as predictors 
of 22-month mortality in medical inpatients. Psychosom Med, 
1998; 60: 570–577.
 8. Hosseini SH, Yousefnejad K, Tabiban S et al. Effects of de-
pression and anxiety symptoms on cardiac mortality following 
myocardial infarction: A 2-year follow-up. Int J Psychiatry Clin 
Pract, 2011; 15: 91–96.
 9. Lane D, Carroll D, Ring C, Beevers DG, Lip GY. Mortality and 
quality of life 12 months after myocardial infarction: Effects of 
depression and anxiety. Psychosom Med, 2001; 63: 221–230.
 10. Lespérance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-
-year risk of cardiac mortality in relation to initial severity and 
one-year changes in depression symptoms after myocardial in-
farction. Circulation, 2002; 105: 1049–1053.
 11. Lane D, Carroll D, Ring C, Beevers DG, Lip GY. In-hospital 
symptoms of depression do not predict mortality 3 years after 
myocardial infarction. Int J Epidemiol, 2002; 31: 1179–1182.
 12. Grasbeck A, Rorsman B, Hagnell O, Isberg PE. Mortality of 
anxiety syndromes in a normal population: The Lundby study. 
Neuropsychobiology, 1996; 33: 118–126.
 13. Holwerda TJ, Schoevers RA, Dekker J, Deeg DJH, Jonker C, 
Beekman ATF. The relationship between generalized anxiety 
disorder, depression and mortality in old age. Int J Geriatr Psy-
chiatry, 2007; 22: 241–249.
www.cardiologyjournal.org 377
Seyed Hamzeh Hosseini et al., Anxiety and depression as predictors of MI mortality
 14. Lavretsky H, Mistry R, Bastani R et al. Symptoms of depression 
and anxiety predict mortality in elderly veterans enrolled in the 
UPBEAT program. Int J Geriatr Psychiatry, 2003; 18: 183–184.
 15. Lee WE, Wadsworth ME, Hotopf M. The protective role of trait 
anxiety: A longitudinal cohort study. Psychol Med, 2006; 36: 345–351.
 16. World Health Organization. WHO MONICA manual. World He-
alth Organization, Geneva 1996.
 17. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory 
for measuring depression. Arch Gen Psychiatry, 1961; 4: 561–571.
 18. Ghassemzadeh H, Mojtabai R, Karamghadiri N, Ebrahimkhani N. 
Psychometric properties of a Persian-language version of the 
Beck Depression Inventory; second edition. BDI-II-PERSIAN. 
Depress Anxiety, 2005; 21: 185–192.
 19. Lespé rance F, Frasure-Smith N, Talajic M, Cameron O. Major 
depression before and after myocardial infarction: Its nature and 
consequences. Psychosom Med, 1996; 58: 99–112.
 20. Bastani F, Hidarnia A, Kazemnejad A, Vafaei M, Kashanian M. 
A randomized controlled trial of the effects of applied relaxation 
training on reducing anxiety and perceived stress in pregnant 
women. J Midwifery Womens Health, 2005; 50: e36–e40.
 21. Dadsetan P, Mansour M. Mental illness. Roshd Press, Tehran 
1998 [in Persian].
 22. Spielberger CD, Gorsuch RL, Luschene RE. Manual for the 
State-Trait Anxiety Inventory. Consulting Psychologists Press, 
Palo Alto, CA 1970.
 23. Schoevers RA, Geerlings MI, Beekman ATF et al. Association 
of depression and gender with mortality in old age. Results from 
the Amsterdam Study of the Elderly (AMSTEL). Br J Psychiatry, 
2000; 177: 336–342.
 24. Holwerda TJ, Schoevers RA, Dekker J, Deeg DJH, Jonker C, 
Beekman ATF. The relationship between generalized anxiety 
disorder, depression and mortality in old age. Int J Geriatr Psy-
chiatry, 2007; 22: 241–249.
 25. Meijer A, Conradi HJ, Bos EH et al. Adjusted prognostic associa-
tion of depression following myocardial infarction with mortality 
and cardiovascular events: Individual patient data meta-analysis. 
Br J Psychiatry, 2013; 203: 90–102.
 26. Louis AA, Manousos IR, Coletta AP, Clark AL, Cleland JGF. Cli-
nical trials update: The Heart Protection Study, IONA, ACUTE, 
ALIVE, MADIT II and REMATCH. Eur J Heart Failure, 2002; 4: 
111–116.
 27. Frasure-Smith N, Lespérance F, Talajic M. Depression and 
18-month prognosis after myocardial infarction. Circulation, 
1995; 91: 999–1005.
 28. Frasure-Smith N, Lespérance F, Talajic M. The impact of nega-
tive emotions on prognosis following myocardial infarction: Is it 
more than depression? Health Psychol, 1995; 14: 388–398.
 29. Irvine J, Basinski A, Baker B et al. Depression and risk of sud-
den cardiac death after acute myocardial infarction: Testing for 
the confounding effects of fatigue. Psychosom Med, 1999; 61: 
729–737.
 30. Ladwig KH, Lehmacher W, Roth R, Briethardt G, Budde T, 
Borggrefe M. Factors which provoke post-infarction depression: 
Results from the Post-Infarction Late Potential Study (PILP). 
J Psychosom Res, 1992; 36: 723–729.
 31. Carroll D, Lane D. Depression and mortality following myo-
cardial infarction: The issue of disease severity. Epidemiologia 
e Psichiatria Sociale, 2002; 11: 65–68.
 32. Frasure-Smith N, Lespé rance F, Talajic M. Depression following 
myocardial infarction: Impact on 6-month survival. J Am Med 
Assoc, 1993; 270: 1819–1825.
 33. Panthee B, Kritpracha C. Review: Anxiety and quality of life 
in patients with myocardial infarction. Nurse Media J Nursing, 
2011; 1: 105–115.
 34. Stordal E, Bjelland I, Dahl AA, Mykletun A. Anxiety and depres-
sion in individuals with somatic health problems. The Nord-
-Trondelag Health Study (HUNT). Scand J Prim Health Care, 
2003; 21: 136–141.
 35. Mykletun A, Overland S, Dahl AA et al. A population-based co-
hort study of the effect of common mental disorders on disability 
pension awards. Am J Psychiatry, 2006; 163: 1412–1418.
 36. Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as 
a risk factor for cardiac mortality and morbidity: A review of 
potential mechanisms. J Psychosom Res, 2002; 53: 897–902.
